CMP Therapeutics

About:

CMP Therapeutics develops chitin microparticles for macrophages and dendritic cells in the nasal and respiratory tract.

Website: http://www.cmptherapeutics.com

Top Investors: Inventages Venture Capital Investment Inc.

Description:

CMP Therapeutics, Ltd., a biopharmaceutical company, develops chitin microparticles (CMP) for macrophages and dendritic cells in the nasal and respiratory tract. The company develops a CMP nasal spray for the treatment of allergic rhinitis, as well as for the clinical applications of nasal spray for enhancing natural resistance to influenza and other respiratory pathogens. Its CMP is also used as an adjuvant in nasal vaccines. The company was founded in 2004 and is based in Bicester, the United Kingdom.